The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
High neutrophil to lymphocyte ratio (NLR) persistence during enzalutamide to predict poor clinical outcome in patients (pts) with metastatic castration-resistant prostate cancer (CRPC).
 
Ugo De Giorgi
Honoraria - Astellas Pharma; Bayer; GlaxoSmithKline; Janssen-Ortho; Pfizer
 
Simon J. Crabb
Honoraria - Bayer; Sanofi
Consulting or Advisory Role - Astellas Pharma; Bayer; Dendreon; Janssen; Pfizer; Sanofi
Research Funding - AstraZeneca
Travel, Accommodations, Expenses - Astellas Pharma; Janssen; Janssen; Novartis; Sanofi
 
Robert J. Jones
No Relationships to Disclose
 
Orazio Caffo
Honoraria - Astellas Pharma; Janssen Oncology; Sanofi
 
Tony Elliott
No Relationships to Disclose
 
Paolo Fabbri
No Relationships to Disclose
 
Lisa Derosa
No Relationships to Disclose
 
Francesco Massari
No Relationships to Disclose
 
Gianmauro Numico
No Relationships to Disclose
 
Vincenza Conteduca
No Relationships to Disclose
 
Sunnya Zarif
No Relationships to Disclose
 
Catherine Hanna
No Relationships to Disclose
 
Francesca Maines
No Relationships to Disclose
 
Helen Joyce
No Relationships to Disclose
 
Emanuela Scarpi
No Relationships to Disclose
 
Dino Amadori
No Relationships to Disclose